Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Filamin A (FLNA) is a large, widely expressed cytoskeletal protein that cross-links actin filaments, acting as a scaffold for numerous signaling proteins. It is essential for cell structure, movement, and signal transduction. Mutations or dysregulation of FLNA are implicated in macrothrombocytopenia, developmental disorders, and cancer.
Not applicable for direct inhibitors/activators; affects downstream signaling and cellular processes through protein-protein interactions and cytoskeletal modulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Filamin A (FLNA).